Literature DB >> 23673402

Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock.

Fabio Silvio Taccone, Alexandre Brasseur, Jean-Louis Vincent, Daniel De Backer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23673402     DOI： 10.1007/s00134-013-2945-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  7 in total

1.  Levosimendan in cardiac failure after subarachnoid hemorrhage.

Authors:  Stefano Busani; Laura Rinaldi; Claudia Severino; Milena Cobelli; Alberto Pasetto; Massimo Girardis
Journal:  J Trauma       Date:  2010-05

2.  Takotsubo cardiomyopathy induced by dobutamine infusion during hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage -case report-.

Authors:  Ryuta Saito; Toshie Takahashi; Nobuo Noshita; Ayumi Narisawa; Ken Negi; Kazuyasu Takei; Uichi Kaneko
Journal:  Neurol Med Chir (Tokyo)       Date:  2010       Impact factor: 1.742

3.  Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities.

Authors:  J G Zaroff; G A Rordorf; J B Newell; C S Ogilvy; J R Levinson
Journal:  Neurosurgery       Date:  1999-01       Impact factor: 4.654

4.  Acute left ventricular dysfunction and subarachnoid hemorrhage.

Authors:  S G Sakka; E Huettemann; K Reinhart
Journal:  J Neurosurg Anesthesiol       Date:  1999-07       Impact factor: 3.956

5.  Cardiogenic shock with stunned myocardium during triple-H therapy treated with intra-aortic balloon pump counterpulsation.

Authors:  Fabio Silvio Taccone; Boris Lubicz; Michael Piagnerelli; Marc Van Nuffelen; Jean-Louis Vincent; Daniel De Backer
Journal:  Neurocrit Care       Date:  2008-09-23       Impact factor: 3.210

6.  Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.

Authors:  Annette D Rieg; Sylvia C Schroth; Oliver Grottke; Marc Hein; Diana Ackermann; Rolf Rossaint; Gereon Schälte
Journal:  Eur J Anaesthesiol       Date:  2009-11       Impact factor: 4.330

Review 7.  Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management?

Authors:  C S A Macmillan; I S Grant; P J D Andrews
Journal:  Intensive Care Med       Date:  2002-07-06       Impact factor: 17.440
  7 in total
  3 in total

1.  Heart Rate Variability as a Biomarker of Neurocardiogenic Injury After Subarachnoid Hemorrhage.

Authors:  Murad Megjhani; Farhad Kaffashi; Kalijah Terilli; Ayham Alkhachroum; Behnaz Esmaeili; Kevin William Doyle; Santosh Murthy; Angela G Velazquez; E Sander Connolly; David Jinou Roh; Sachin Agarwal; Ken A Loparo; Jan Claassen; Amelia Boehme; Soojin Park
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

Review 2.  Takotsubo Cardiomyopathy in Traumatic Brain Injury.

Authors:  Chun Fai Cheah; Mario Kofler; Alois Josef Schiefecker; Ronny Beer; Gert Klug; Bettina Pfausler; Raimund Helbok
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

3.  Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study.

Authors:  Dariusz Onichimowski; Krzysztof Nosek; Radosław Goraj; Rakesh Jalali; Aleksandra Wińska; Aleksandra Pawlos; Bułat Tuyakov
Journal:  Drug Des Devel Ther       Date:  2018-06-20       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.